Interpretation of microarray data in cancer
Open Access
- 6 March 2007
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (8) , 1155-1158
- https://doi.org/10.1038/sj.bjc.6603673
Abstract
Microarray studies aim at identifying homogeneous subtypes of cancer patients, searching for differentially expressed genes in tumours with different characteristics, or predicting the prognosis of patients. Using breast cancer as an example, we discuss the hypotheses underlying these studies, their power, and the validity and the clinical usefulness of the findings.Keywords
This publication has 32 references indexed in Scilit:
- Gene expression profiling: Does it add predictive accuracy to clinical characteristics in cancer prognosis?European Journal Of Cancer, 2007
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- Why Most Published Research Findings Are FalsePLoS Medicine, 2005
- REporting recommendations for tumour MARKer prognostic studies (REMARK)British Journal of Cancer, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- “Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilersEuropean Journal Of Cancer, 2004
- Metastasis genes: A progression puzzleNature, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- What do we mean by validating a prognostic model?Statistics in Medicine, 2000